STRAIGHT ANSWERS · REAL LIFE
Oral semaglutide for weight loss in the UK: what 13.6% means
A tablet is another way to take treatment. It still needs the right prescription, a workable routine and support beyond the headline number.
On this page
Your first month on prescribed tablets: a practical plan
Use this after a prescriber has agreed treatment. It helps you organise the routine, food and follow-up. Your prescription and the leaflet for your exact medicine take priority.
- Before the first tablet: confirm the medicine, prescribed strength, review date and how to reach the service. Give the pharmacist your full medicines and supplements list. Ask how other tablets, diabetes treatment, planned surgery and any health conditions affect the plan.
- Week one — make one routine workable: use the correct timing rules in the tablet comparison. Put the instruction where you will see it. Keep breakfast and coffee consistent with your medicine’s rules. If shifts or other medicines make fasting difficult, ask the pharmacist for a suitable plan rather than skipping necessary food or changing medicine times yourself.
- Week two — protect ordinary eating: plan a manageable lunch and a fallback evening meal for late finishes. Notice if reduced appetite is stopping you eating adequately. Discuss poor intake with your prescribing service. You do not need specialist food or a supplement bundle to organise a routine.
- Week three — check usefulness: ask whether the routine fits, food is manageable and suitable movement feels achievable. Record difficulties plainly. Keep what helped; simplify or change a practical step that did not fit. This is not a decision to change the medicine.
- Before the next prescription: review symptoms, any missed doses and difficulties with your service. Confirm the next prescribed strength and total ongoing cost. Dose increases belong to the prescriber; never take extra tablets to accelerate progress.
I missed a tablet. What now?
- Wegovy tablets: skip the missed dose; take the normal dose the next day.
- Foundayo: take a forgotten dose when you remember, but take no more than one dose per day. Do not double it.
Those are different instructions. Check the leaflet in your pack. After several missed days, or if you vomit after a tablet, ask the pharmacist or prescriber what to do; do not assume you need a replacement dose.
When should I contact my prescriber?
Both tablet leaflets list nausea, vomiting, diarrhoea and constipation. Report symptoms that persist, interfere with eating or make ordinary activities difficult. Repeated vomiting or difficulty keeping fluids down needs urgent advice.
Severe, persistent abdominal pain, including pain spreading to the back, needs immediate medical help. The Wegovy leaflet says to stop treatment and seek urgent help for this warning sign. For breathing difficulty, throat swelling or collapse, call 999. Sudden vision loss or rapidly worsening sight needs urgent assessment. Do not wait for a My Timber check-in or a reply from SHIFT.
What should I record for a useful review?
Keep the start date, prescribed dose and changes, missed days, symptoms and what happened to eating and daily function. If weight tracking is helpful for you, use comparable readings over time. Early weeks often involve gradual dose increases; a first-month reading is not a verdict on long-term treatment.
Use My Timber for the practical part
Open My Timber’s Today screen and look for “Your tablet routine”. If these tablets have already been prescribed for you, optional health tracking lets you save a routine, return for a first-week check-in and say whether a practical step helped. You can use routine support when treatment was arranged elsewhere. Saving a check-in does not contact a clinician; nobody monitors it for symptoms. Medicine decisions stay with your prescribing service.
For everyday support, use food and meal planning and manageable movement and starting steps.
Questions before choosing: tablet or injection, switching and continuing cost. For the other authorised pill, read Foundayo’s daily routine.
Sources: MHRA: Wegovy tablets authorised, 11 June 2026; MHRA: Foundayo authorised, 10 August 2026; UK Wegovy tablet leaflet, revised June 2026; UK Foundayo leaflet, revised August 2026.
Practical section added and its linked sources checked 6 October 2026 by the SHIFT editorial team. These are general examples, not a personal diet, exercise or treatment prescription. Independent clinical review is not claimed.

Is oral semaglutide approved in the UK?
Yes. The MHRA approved Wegovy tablets for weight management on 11 June 2026. The licence covers adults with a BMI of at least 30, or at least 27 with a weight-related condition, alongside diet and activity changes. A prescriber must assess suitability.
The approval announcement explicitly said the tablet was not then available through the NHS. A UK licence does not establish NHS funding, local access or stock at SHIFT. Check the current pathway with your clinician. Read the MHRA announcement.
What does 13.6% weight loss actually mean?
In OASIS 4, 307 adults without diabetes were allocated to oral semaglutide 25 mg or placebo. At week 64, estimated average body-weight change was −13.6% with semaglutide and −2.2% with placebo. These are trial averages, not a promise of your result, and body-weight loss is not the same as pure fat loss.
The trial compared the tablet with placebo, not directly with Mounjaro or a Wegovy injection. It cannot establish which option would work best for you. Gastrointestinal adverse events occurred in 74% of the semaglutide group and 42.2% of the placebo group. Read the original OASIS 4 study.
What is different about taking a tablet?
The approved daily dose starts at 1.5 mg and rises through 4 mg, 9 mg and 25 mg, spending at least a month at each level. Follow the prescription and leaflet; do not jump to the headline trial dose yourself.
The MHRA describes taking the tablet whole after at least eight hours without food, with a sip of water, then waiting at least 30 minutes before food or drink. Ask your pharmacist how other morning medicines fit around it. Official dosing information.
A tablet removes the injection, but adds a daily routine. Before choosing, think about your actual mornings: shifts, breakfast, school runs and other medicines. A treatment that looks convenient on paper still needs to fit your day.
Side effects and when to get help
Nausea, vomiting, constipation and diarrhoea are recognised side effects. Tell your prescriber about your medical history and every medicine or supplement you take. Semaglutide is not used during pregnancy or breastfeeding; discuss planned pregnancy with your clinician.
Seek urgent medical advice for severe, persistent abdominal pain, particularly if it reaches your back, sudden vision loss, or symptoms that leave you unable to keep fluids down. Call 999 for a serious allergic reaction with breathing difficulty or swelling of the throat or tongue. NHS semaglutide safety information.
This is not a complete safety checklist or a personal dosing plan. Use the leaflet supplied with your exact product and contact your prescriber or pharmacist about side effects and changes to treatment.
What should you check before paying?
Ask who assesses you, who prescribes and which registered pharmacy dispenses. Get the total price at later doses, any consultation or delivery charges, and the cancellation terms. Ask how you contact someone if side effects make treatment difficult.
Do not mistake an introductory price for the ongoing cost. Ask whether the quoted supply covers four weeks or a calendar month, and whether support is included. Our Wegovy cost guide explains the questions to ask.
This guide is information, not an offer to prescribe or dispense medication. Speak to a qualified prescriber or pharmacist about whether any treatment is suitable for you.
SHIFT’s take: plan for life around the treatment
The useful question is bigger than “pill or pen?” It is “what helps me keep going on an ordinary Tuesday?” Food you can manage, movement that fits, a place to check in, and someone qualified to contact about the prescription all matter.
SHIFT’s Programme brings practical food, movement and Life Back support together. You can explore it whether your medication comes from elsewhere, you are considering treatment, or you have stopped. Clinical decisions remain with your prescriber.
If you are thinking about stopping, use our coming-off guide to prepare for that conversation. If your provider has become hard to reach, Clinic Gone Quiet explains SHIFT’s support and its boundaries. We do not replace urgent care or your prescribing team.
Questions worth taking to your prescriber
- Is this exact product suitable for my history and other medicines?
- How should I fit it around breakfast and my normal routine?
- Who do I contact between appointments, and when should I seek urgent help?
- What happens if I cannot tolerate it, supply changes, or I want to stop?
- What is included in the continuing cost?
You do not need to arrive with the right answers. You need a clear route to getting them.
About the author
Matt O’Brien · Founder, SHIFT Some Timber
Matt founded SHIFT to help ordinary men build practical routines around food, movement and getting their life back.
Sources and editorial note
By Matt O’Brien, founder of SHIFT Some Timber. Sources checked 20 September 2026. General information, not an individual treatment recommendation. No independent clinical review is claimed.
- MHRA: Wegovy tablet approval, 11 June 2026
- Wharton and colleagues: OASIS 4, New England Journal of Medicine, 2025
- NHS: semaglutide
Explore the Programme · Open My Timber
Last updated .
SHIFT does not currently prescribe or supply medicines.
